It’s Time to Review the Research Behind Pediatric Gender Medicine

Earlier this month the Do No Harm team attended the Endocrine Society’s Annual Meeting in Chicago, hosting a booth and urging members to reassess the nature and scope of its commitment to “gender-affirming care” so that American endocrinologists can provide the best evidence-based treatment for minors.

---

As part of our efforts on-site, we also published this commentary by Do No Harm Senior Fellow Dr. Roy Eappen and used significant digital advertising to spread our message to those attending the conference.

Our experience confirmed what we have long suspected: medical organizations like the Endocrine Society are putting political demands ahead of the scientific process and patients’ needs, and that most practicing endocrinologists are deeply concerned about the Society’s elevation of transgender activism and would prefer strong guardrails to protect adolescents and children from a rush to transition.

In fact, not only do they have serious concerns, they are afraid to speak up about those concerns due to the political pressure they have faced since the Society came out in support of these treatments in 2017.

The Society has made it clear: those who do not walk the line will be ostracized.

We also spoke with numerous European endocrinologists who expressed genuine shock that the United States has not followed their lead and restricted – or outright prohibited – treatments for adolescents and children.

As we have previously shared, nations across Europe have instituted bans and noted that the science behind such treatments is sorely lacking – and in evaluating what science does exist, the risks to children far outweigh any benefits.

Do No Harm is calling on the Endocrine Society to withdraw its guidelines and conduct a thorough review of the latest research, much like European countries have done.

We will continue taking the fight to stop the woke takeover of medicine where it matters most.